Next Article in Journal
Multiscale Encoding of Electrocardiogram Signals with a Residual Network for the Detection of Atrial Fibrillation
Next Article in Special Issue
Assessing Tumorigenicity in Stem Cell-Derived Therapeutic Products: A Critical Step in Safeguarding Regenerative Medicine
Previous Article in Journal
Therapeutic Applications of the CRISPR-Cas System
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Analysis of NanoLuc Luciferase and Alkaline Phosphatase Luminescence Reporter Systems for Phage-Based Detection of Bacteria

Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011, USA
*
Author to whom correspondence should be addressed.
Bioengineering 2022, 9(9), 479; https://doi.org/10.3390/bioengineering9090479
Submission received: 13 July 2022 / Revised: 19 August 2022 / Accepted: 25 August 2022 / Published: 16 September 2022
(This article belongs to the Special Issue Bioanalysis Systems: Materials, Methods, Designs and Applications)

Abstract

:
Reporter phage assays are a promising alternative to culture-based assays for rapidly detecting viable bacteria. The reporter systems used in phage-based detection are typically enzymes and their corresponding substrates that provide a signal following infection and expression. While several reporter systems have been developed, comparing reporter systems based on reported bacteria detection limits from literature can be challenging due to factors other than the reporter system that influence detection capabilities. To advance the development of phage-based assays, a systematic comparison and understanding of the components are necessary. The objective of this study was to directly compare two common enzyme-mediated luminescence reporter systems, NanoLuc/Nano-Glo and alkaline phosphatase (ALP*)/DynaLight, for phage-based detection of bacteria. The detection limits of the purified enzymes were determined, as well as the expression levels and bacteria detection capabilities following engineering of the coding genes into T7 phage and infection of E. coli BL21. When comparing the sensitivity of the purified enzymes, NLuc/Nano-Glo enzyme/substrate system demonstrated a lower detection limit than ALP*/DynaLight. In addition, the expression of the NLuc reporter following phage infection of E. coli was greater than ALP*. The lower detection limit combined with the higher expression resulted in a greater than 100-fold increase in sensitivity for the NLuc/Nano-Glo® reporter system compared to ALP*/DynaLight when used for the detection of E. coli in a model system. These findings provide a comparative analysis of two common reporter systems used for phage-based detection of bacteria and a foundational understanding of these systems for engineering future reporter phage assays.

1. Introduction

Bacteriophage (or phage) are a type of virus that infect and multiply within viable bacterial host cells [1]. Following infection, phage use their host to transcribe and translate the phage DNA, generating phage proteins and enzymes within a matter of hours or less [2,3,4]. These properties have been utilized to develop reporter phage assays to detect bacteria. Reporter phage-based assays are often built by genetically modifying phage genomes to express specific reporter proteins during infection. Detection of the expressed reporter proteins is used as a surrogate to indicate the presence of bacteria [5,6,7]. Reporters used in phages are typically enzymes that can give a detectable signal through a comprehensive range of output mechanisms such as electrochemical [8], colorimetry [5,7,9,10,11,12], fluorescence [13,14,15,16], or luminescence [5,17,18,19] upon interacting or reacting with an exogenous substrate. Of these methods, luminescence offers advantages over the other analytical techniques by having comparatively high sensitivity and extended linear responses [20].
Two common reporters employed in luminescence detection systems are alkaline phosphatase and NanoLuc luciferase. Alkaline Phosphatase (ALP) is a metalloid enzyme that hydrolyzes phosphoric esters [21]. The bacterial gene PhoA encodes the dimeric ALP for its phosphate metabolism [22,23,24]. ALP enzyme activity can be readily detected through several mechanisms such as electrochemical [25], colorimetric [10], fluorescence [14], and luminescence [7]. Recently, the efficacy of the enzyme has been improved by developing a double mutant ALP (ALP*), which increased the catalytic activity of the wild-type enzyme 40-fold [26]. Research shows that the gene of the mutant ALP* can be integrated into the genome of bacteriophage and expressed from Escherichia coli (E. coli) with conserved activity [7,10,14,27]. NanoLuc luciferase (NLuc) is a commercially available luciferase enzyme produced by Promega Corporation. The single subunit enzyme is obtained from the deep-sea shrimp Oplophorus gracilirostris and optimized to react with the synthetic substrate imidazopyrazinone (Nano-Glo®, Promega Corporation, Madison, WI, USA), resulting in a specific activity 150-fold greater than other class members such as firefly luciferase or Renilla luciferase [28]. The smaller size (19 kD), high thermostability, and high specific activity have made the NLuc enzyme a popular candidate as a reporter protein in gene recombination technology [19,29,30].
In addition to the specific enzyme/substrate reporter system, factors such as the species of phage, the reporter gene location, the presence/absence and type of signaling peptide, species, and strain of host cell, duration of infection, cell enrichment time, phage concentration, and the presence/absence and type of fusion tag can influence detection. As such, comparing reporter systems from literature results is challenging. In order to advance the development of phage-based assays, a systematic understanding and comparison of components are necessary. The objective of this study was to directly compare two enzyme-mediated luminescence reporter systems, NanoLuc/Nano-Glo and ALP*/DynaLight, for phage-based detection of bacteria in a model system. To achieve this objective, the detection limits of purified ALP* and Nluc, when used with their respective substrates, were determined. Genes coding for the enzymes were engineered into T7 phage, and expression levels and bacteria detection capabilities of the two enzymes were evaluated following infection of E. coli BL21.

2. Materials and Methods

2.1. ALP* and NLuc Constructs

NanoLuc Luciferase (NLuc) and double mutant (D135G/D330N) Alkaline Phosphatase (ALP*) enzymes were selected as the reporter enzymes to generate luminescence signals. Genbank accession numbers for NLuc and ALP* genes are JQ437370.1 and M29664.1, respectively. pET20b(+)NLuc plasmid was synthesized by GenScript Biotech. pET20b(+)ALP* was obtained from Professor Robert S. Haltiwanger, Complex Carbohydrate Research Center, University of Georgia. The pET20b(+) plasmids of ALP* and NLuc were designed without any secretory signal peptide sequences to retain the protein expression and activity at their native forms [31]. Therefore, the pelB sequence of the pET20b(+) vector was removed during plasmid synthesis. Both genes were designed to have C-terminal poly-histidine affinity tags (Scheme 1a).

2.2. Expression and Purification of ALP* and Nluc

The plasmid constructs from Genscript Biotech were transformed into NEB Express E. coli Bl21 cells. Transformed colonies were selected from LB agar plates with ampicillin at 100 μg/mL. A single colony was allowed to grow overnight, and 10 mL of the grown culture was added to 1 L of media until the OD reached 0.7. The 1 L culture of cells was induced with 200 μM IPTG and allowed to grow at 20 °C for another 18 h at 150 RPM. The cells were harvested by centrifugation at 5000 RPM for 45 min at 4 °C. The cell pellet was lysed using Bugbuster® (MiliporeSigma, Burlington, MA, USA) solution diluted by 10% with equilibration buffer (50 mM sodium phosphate, 300 mM sodium chloride at pH 8) containing 10 mM imidazole, 1 mM PMSF, and 10 μg/mL DNAase. The cell suspension was mixed at 200 RPM for 30 min at room temperature, and the supernatant was obtained through centrifugation at 5000 RPM for 45 min at 4 °C. The supernatant was filtered using a 0.45 μm PVDF (Polyvinylidene Fluoride) filter and diluted proportionally with an equilibration buffer containing 10 mM imidazole. A glass chromatography column was packed with 500 μL of HisPur Ni-NTA resin (Thermo Fisher Scientific, Waltham, MA, USA) pre-equilibrated with equilibration buffer (50 mM sodium phosphate, 300 mM sodium chloride at pH 8) containing 10 mM imidazole. The diluted supernatant was passed through the packed column three times to allow maximum binding of the protein. The resin was washed with equilibration buffer containing 30 mM imidazole to remove non-specific protein. The reporter protein was eluted using an equilibration buffer containing 250 mM imidazole and concentrated using filter columns. ALP* protein was buffer exchanged with 50 mM Tris containing 10 mM magnesium chloride at pH 8, and NLuc protein was buffer exchanged with 50 mM phosphate buffer. The concentrated proteins were confirmed through SDS-PAGE, and the concentration was determined through the Bradford assay.

2.3. Enzyme Activity of Purified ALP* and NLuc

The purified NLuc and ALP* proteins were serially diluted to obtain solutions of 10–2 fmol/µL. To determine the enzyme activity of NLuc protein, Nano-Glo® substrate was used, while for ALP* protein, DynaLight (Thermo Fisher Scientific, Waltham, MA, USA) substrate was used. For dilutions and blank samples, 50 mM phosphate buffer was used for NLuc protein, and 50 mM Tris containing 10 mM magnesium chloride was used for ALP* protein. A total of 30 µL of each protein dilution was mixed with 30 µL of the substrate solution. All reagents were allowed to come to room temperature, and the reactions were performed in black/brown microcentrifuge tubes. Twenty-five microliters of the reaction mixture were added to a 384-solid white microplate. The surrounding wells of each occupied well were kept empty to avoid well-to-well crosstalk signal. The Relative Luminescence Units of each sample were measured using Biotek® (Synergy H1) microplate reader (BioTek, Vinooski, VT, USA) with luminescence mode, 135 gain setting, and a two-second integration time. Signal to noise (S/N) ratio was determined from the response at each concentration in relation to the response of the blank. Limit of detection (LoD) was estimated from regression analysis at concentrations corresponding to a S/N ratio of 3:1 using GraphPad® Prism 8.2.0 (Graphpad Software, San Diego, CA, USA). Experiments were performed in triplicate.

2.4. Construction of Reporter Phages ALP* and Nluc

Commercially prepared T7Select® cloning kit (MiliporeSigma, Burlington, MA, USA) was used as the phage cloning vector, which allowed the insertion of a reporter gene in substitution of a phage capsid gene [32]. The primer design and cloning of the reporters to phage vectors were carried out according to the guidelines in the T7Select® cloning kit user manual. Genes coding for ALP* and NLuc were amplified using primers listed in Table 1 to prepare for the recombination with the phage genome (Scheme 1b) [33,34]. The restriction sites were used to obtain the specific sticky ends in the inserts for the ligation with the phage vector arms. The stop codons in the forward and reverse primers were employed to express the reporter individually and not as a fusion of the phage capsid protein [10]. The amplified PCR products were extracted using agarose gel electrophoresis, where bands were observed for ALP* insert (~1350 bp) and NLuc insert (~531 bp) relative to the 1 kb DNA ladder and confirmed using Sanger sequencing. The extracted and purified PCR products of the reporter gene inserts (0.04 pmol/µL) were digested with EcoRI and HindIII restriction enzymes. The ligation reaction was carried out using the digested reporter genes (1.5 µL) and the T7Select® phage vector arms (1 µL of 0.02 pmol/µL) to have the reporter gene to vector arms at a 3:1 molar ratio. The finished ligation reaction was directly added to the T7Select® Packaging Extracts provided by the cloning kit for in vitro packaging. The packaged phages were confirmed for viability and amplified through the double agar overlay plaque assay. The DNA of several plaques was extracted, amplified by PCR, and subjected to Sanger sequencing to confirm the presence of the reporter gene insert. The background reporter protein of the phage stock was removed by passing the stock through a nickel-NTA resin-packed column until a minimal luminescence signal was detected. Concentrations of the final phage stocks were determined using a double agar overlay plaque assay.

2.5. Quantitation of Reporter Protein through the Phage Assay

A total of 45 mL of the diluted phage solution (107 PFU/mL) was mixed with 4.5 mL of a diluted overnight culture of E. coli BL21 cells (107 CFU/mL) in a 50 mL centrifuge tube. A total of 45 mL of the same phage solution was mixed with 4.5 mL of LB as the control. The tubes were incubated at 37 °C at 175 RPM for 2 h. After the incubation, the phage-E. coli mixtures were passed through a glass chromatography column packed with 500 μL of HisPur Ni-NTA resin. The resin was pre-equilibrated with equilibration buffer (50 mM sodium phosphate, 300 mM sodium chloride at pH 8) containing 10 mM imidazole. The column was washed with equilibration buffer containing 30 mM imidazole. The reporter protein was eluted using an equilibration buffer containing 250 mM imidazole and concentrated using filter units. ALP* protein was buffer exchanged with 50 mM Tris containing 10 mM magnesium chloride at pH 8, and NLuc protein was buffer exchanged with 50 mM phosphate buffer. NanoOrange Protein Quantitation Kit (Thermo Fisher Scientific, Waltham, MA, USA) protocol was followed to quantify the amount of reporter enzyme of each engineered phage. Briefly, 100 μL of each concentrated protein was added to 2.4 mL of NanoOrange working stock dye, heated for denaturation of the protein, and cooled before measuring the fluorescence. The relative fluorescence units (RFU) were measured using a BioTek® plate reader with an excitation at 485 nm and emission capturing at 590 nm. A standard curve was generated using bovine serum albumin protein (BSA; 0.1 ng/mL–2 mg/mL) with NanoOrange dye to determine the concentrations of the reporter protein. The protein amounts obtained from the control were subtracted from the experiment to get the total amount of reporter proteins expressed through the engineered phages upon infection. Molecular weights of 19 kD for NLuc reporter and 96 kD for ALP* reporter were taken when calculating molecules of protein expressed per E. coli cell. All experiments were performed in triplicate, and the data were expressed as the mean ± standard deviation. The statistical analysis through GraphPad® Prism software was used to perform statistics with a p < 0.05 indicating a statistically significant difference.

2.6. Limit of Detection of Reporter Phage for E. coli

Reporter phage stocks NLuc and ALP* were diluted to obtain 109 PFU/mL. An overnight culture of E. coli BL21 cells was serially diluted to obtain 10 to 1010 CFU/mL cultures. A total of 800 μL of the 109 PFU/mL phage stock was mixed with 80 μL of each E. coli BL21 dilution. A total of 800 μL of the 109 PFU/mL phage stock was mixed with 80 μL of LB as the blank experiment. The mixtures were incubated at 37 °C with 175 RPM for 2 h to allow complete infection of E. coli cells and expression of the reporter protein. Following incubation, the samples were centrifuged (3000× g, 3 min) to pellet any cell debris. The supernatant of each dilution was collected to determine the luminescence activity of each reporter according to the procedure in Section 2.3 [35].

3. Results

3.1. Expression and Purification of ALP* and NLuc

To determine the detection limits of ALP* and NLuc with their respective substrates in solution, the two enzymes were cloned, expressed, and purified. Both enzymes could be expressed in the soluble fraction of the cell lysate (Figure 1). The monomeric NLuc protein showed a band along its respective size (19 kD), and the dimeric ALP* showed a band at its single subunit size of ~48 kD in the SDS-PAGE gel. Though ALP* has an active site in each subunit, the protein’s high catalytic activity depends on the formation of a dimer [36]. The SDS-PAGE gel confirmed previous reports that NLuc and ALP* proteins are expressed in the bacterial cytoplasm [37,38]. While genes for both reporters were designed without sequences to promote secretion in the periplasm, ALP* showed protein expression in the cell medium in the absence of secretory signals. This unexpected phenomenon could be attributed to undefined signal peptides within the gene sequence [39]. Following Ni-NTA column purification, 0.25 mg of ALP* and 0.3 mg of NLuc could be recovered from 1 L cultures.

3.2. Enzyme Activity of Purified ALP* and NLuc

A linear response was observed as a function of protein concentration for both purified enzymes in combination with their luminescent substrates. Based on an S/N ratio of 3:1 and molecular weights 96 kD and 19 kD assumed for ALP* and NLuc, the detection limits for the defined assays were estimated at 0.31–0.42 fmol/μL (9.4–12.5 fmol/reaction) for ALP*/DynaLight and 0.01–0.03 fmol/μL (0.3–0.93 fmol/reaction) NLuc/Nano-Glo® (Figure 2).

3.3. Construction of Reporter Phages ALP* and NLuc

Recombinant T7 phages with reporter gene inserts were amplified using an exponentially growing E. coli BL21 cells culture to ensure efficient phage infection and replication. Visible plaques were observed in the plaque assays, confirming the reporter genes’ successful ligation into the phage genome. The lysis time of the cell culture and plaque sizes were similar to the control phage synthesized by the T7Select® cloning kit (Figure A1), suggesting that the gene inserts did not affect the fitness of the recombinant phages. PCR amplification of the extracted DNA from a single plaque and agarose gel electrophoresis confirmed the presence of the reporter genes in each engineered phage. Sanger sequencing further confirmed no significant mutations in the reporter genes. Phage stock concentrations were calculated to be 5.4 × 1010 PFU/mL and 5.5 × 1010 PFU/mL for T7ALP* and T7NLuc, respectively.

3.4. Quantitation of Reporter Protein through the Phage Assay

While the enzyme’s catalytic activity, in combination with the sensitivity of the specific substrate, is essential to the detection capabilities, protein expression levels through the host must also be considered when selecting a reporter for phage assays [8,16,31]. To determine expression, infection of the bacterial cells was maintained using a 10-fold concentration of phage relative to CFUs of E. coli. With the assumptions that the infection of all E. coli cells by at least one recombinant phage and that the purified protein was entirely reporter, the average molecules of reporter expressed per colony forming unit (CFU) was calculated to be ~9.8 × 105 molecules (~1.6 attomoles) for T7NLuc and ~8.6 × 104 molecules (0.14 attomoles) for T7ALP* * (Figure 3). These results indicate that T7NLuc is able to express significantly more (p = 0.0132) reporter molecules/CFU than T7ALP*.

3.5. Limit of Detection of Reporter Phage for E. coli

A series of overnight grown E. coli BL21 concentrations were prepared to determine the limit of detection when using the recombinant phages in a model system. Overnight bacterial cultures were used to mimic the stationary phase E. coli that would be present in field samples. A fixed and higher phage concentration was used to achieve infection of all E. coli cells and maintain the initial culture concentrations. Based on an S/N ratio of 3:1, the limit of detection of T7ALP* was determined to be within 8 × 107 CFU/mL–8 × 108 CFU/mL, while the limit of detection for T7NLuc was within 8 × 105 CFU/mL–8 × 106 CFU/mL relative to the phage-only negative control (Figure 4).

4. Discussion

The genome of T7 phage can be genetically engineered to successfully express catalytically-active alkaline phosphatase and NanoLuc reporter enzymes following infection of E. coli BL21 cells. While both reporter phages can be used for the luminescence-based detection of E. coli in a model system, T7NLuc is superior to T7ALP* with respect to bacteria detection sensitivity. The lower limit of detection attributed to T7NLuc when using Nano-Glo® is attributed to a more sensitive enzyme/substrate system and a higher protein expression level. With respect to the enzyme/substrate system, NLuc/Nano-Glo® demonstrated a lower background, a steeper slope, and a detection threshold ~10-fold greater than the ALP*/DynaLight™ system, suggesting the NLuc/Nano-Glo® is the more sensitive luminescent system [40,41]. Increased protein expression is likely a function of the smaller size of NLuc phage (~531 bp/~19 kD) compared to ALP* (~1350 bp/~96 kD). A smaller sequence may enhance transcription, translation, and subsequent mean abundance of protein per cell [42]. These expression values are aligned with the reported expression of a maltose binding protein-tobacco etch virus (TEV) protease fusion protein (~2048 bp/~72 kD) that was estimated to be ~2 × 105 molecules per host cell [8,16]. However, as evident by the SDS-PAGE gel, His-tag purification of ALP* resulted in additional proteins collected in the purified ALP*. We hypothesized that these additional bands to be proteolyzed ALP or native E. coli proteins that had an affinity to Ni-NTA. The additional proteins in the purified ALP* could risk overestimating the total expressed reporter of ALP* phage during the assay procedure. A more specific His-tag purification system of the reporter such as using a cobalt-based resin, may improve the purity of the expressed ALP* and provide more accurate quantitation of the phage expressed reporter.
While the results indicate that direct detection of E. coli is possible using T7 phage with an NLuc or ALP* reporter, modifying the reporter or assay system may enhance sensitivity. For example, Pulkkinen and others engineered a T7 phage that would express an NLuc reporter upon E. coli infection [19]. The NLuc reporter was modified to include a PelB-leader sequence to foster expression and a carbohydrate-binding module (CBM) to enable downstream immobilization. Using this system, a detection limit of 47 CFU per well was achieved. Hinkley and others also utilize an NLuc-CBM fusion reporter and T7 phage to achieve a limit of detection of less than 10 CFU/mL [43]. NLuc reporter was fused with CBM to concentrate the expressed NLuc reporter on microcrystalline cellulose. In addition, the detection system included an initial growth step of 1–5 h to increase the number of bacterial cells in the sample. ALP* has also been fused with CBM to enable concentration of the reporter following host infection. Singh and others were able to achieve detection limits of <10 CFU/mL using these concentration strategies along with enrichment steps [4]. These examples demonstrate the potential of reporter modifications to improve phage-based bacterial detection systems. However, other assay factors, such as the incubation time, incubation volume, reaction volume, phage type, phage concentration, and readout method, can also influence the sensitivity (Table 2).
Collectively, the attributes of T7Nluc enable an approximately 100-fold enhancement in sensitivity for the detection of E. coli BL21 when compared to T7ALP*. These findings provide a comparative analysis of two common reporter systems used for phage-based detection of bacteria and a foundational understanding of the components for systematic engineering of future phage-based detection assays.

Author Contributions

Conceptualization, J.T., A.B., and S.W.; methodology, J.T., A.B., and S.W.; validation; A.B. and S.W.; formal analysis, J.T. and S.W.; investigation, A.B. and S.W.; resources, J.T.; data curation, S.W.; writing—original draft preparation, S.W.; writing—review and editing, J.T. and S.W.; visualization, S.W.; supervision, J.T.; project administration, J.T.; funding acquisition, J.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the USDA National Institute of Food and Agriculture NNF award (2017–38420–26769).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Figure A1. Plaques produced by Control phage (ac), ALP* phage (df), and NLuc phage (gi). Each row is dedicated to a recombinant phage and the three dilutions used for each phage (10−7 PFU/mL to 10−9 PFU/mL) show from left to right.
Figure A1. Plaques produced by Control phage (ac), ALP* phage (df), and NLuc phage (gi). Each row is dedicated to a recombinant phage and the three dilutions used for each phage (10−7 PFU/mL to 10−9 PFU/mL) show from left to right.
Bioengineering 09 00479 g0a1

References

  1. Clokie, M.R.J.; Millard, A.D.; Letarov, A.V.; Heaphy, S. Phages in nature. Bacteriophage 2011, 1, 31–45. [Google Scholar] [CrossRef] [PubMed]
  2. Paczesny, J.; Richter, Ł.; Hołyst, R. Recent progress in the detection of bacteria using bacteriophages: A review. Viruses 2020, 12, 845. [Google Scholar] [CrossRef] [PubMed]
  3. Meile, S.; Sarbach, A.; Du, J.; Schuppler, M.; Saez, C.; Loessner, M.J.; Kilcher, S. Engineered reporter phages for rapid bioluminescence-based detection and differentiation of viable Listeria cells. Appl. Environ. Microbiol. 2020, 86, e00442-20. [Google Scholar] [CrossRef] [PubMed]
  4. Singh, S.; Hinkley, T.; Nugen, S.R.; Talbert, J.N. Colorimetric detection of Escherichia coli using engineered bacteriophage and an affinity reporter system. Anal. Bioanal. Chem. 2019, 411, 7273–7279. [Google Scholar] [CrossRef]
  5. Burnham, S.; Hu, J.; Anany, H.; Brovko, L.; Deiss, F.; Derda, R.; Griffiths, M.W. Towards rapid on-site phage-mediated detection of generic Escherichia coli in water using luminescent and visual readout. Anal. Bioanal. Chem. 2014, 406, 5685–5693. [Google Scholar] [CrossRef]
  6. Petrenko, V.A. Landscape phage: Evolution from phage display to nanobiotechnology. Viruses 2018, 10, 311. [Google Scholar] [CrossRef]
  7. Jackson, A.A.; Hinkley, T.C.; Talbert, J.N.; Nugen, S.R.; Sela, D.A. Genetic optimization of a bacteriophage-delivered alkaline phosphatase reporter to detect: Escherichia coli. Analyst 2016, 141, 5543–5548. [Google Scholar] [CrossRef] [PubMed]
  8. Wang, D.; Hinkley, T.; Chen, J.; Talbert, J.N.; Nugen, S.R. Phage based electrochemical detection of: Escherichia coli in drinking water using affinity reporter probes. Analyst 2019, 144, 1345–1352. [Google Scholar] [CrossRef]
  9. Alcaine, S.D.; Law, K.; Ho, S.; Kinchla, A.J.; Sela, D.A.; Nugen, S.R. Bioengineering bacteriophages to enhance the sensitivity of phage amplification-based paper fluidic detection of bacteria. Biosens. Bioelectron. 2016, 82, 14–19. [Google Scholar] [CrossRef]
  10. Hinkley, T.C.; Singh, S.; Garing, S.; Le Ny, A.L.M.; Nichols, K.P.; Peters, J.E.; Talbert, J.N.; Nugen, S.R. A phage-based assay for the rapid, quantitative, and single CFU visualization of E. coli (ECOR #13) in drinking water. Sci. Rep. 2018, 8, 14630. [Google Scholar]
  11. Hoang, H.A.; Dien, L.T. Rapid and simple colorimetric detection of escherichia coli O157:H7 in apple juice using a novel recombinant bacteriophage-based method. Biocontrol Sci. 2015, 20, 99–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Laube, T.; Cortés, P.; Llagostera, M.; Alegret, S.; Pividori, M.I. Phagomagnetic immunoassay for the rapid detection of Salmonella. Appl. Microbiol. Biotechnol. 2014, 98, 1795–1805. [Google Scholar] [CrossRef] [PubMed]
  13. Vinay, M.; Franche, N.; Grégori, G.; Fantino, J.R.; Pouillot, F.; Ansaldi, M. Phage-Based Fluorescent Biosensor Prototypes to Specifically Detect Enteric Bacteria Such as E. coli and Salmonella enterica Typhimurium. PLoS ONE 2015, 10, e0131466. [Google Scholar] [CrossRef] [PubMed]
  14. Wisuthiphaet, N.; Yang, X.; Young, G.M.; Nitin, N. Rapid detection of Escherichia coli in beverages using genetically engineered bacteriophage T7. AMB Express 2019, 9, 55. [Google Scholar] [CrossRef]
  15. Lemon, D.J.; Kay, M.K.; Titus, J.K.; Ford, A.A.; Chen, W.; Hamlin, N.J.; Hwang, Y.Y. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018. J. Microbiol. 2019, 57, 532–538. [Google Scholar] [CrossRef]
  16. Alcaine, S.D.; Tilton, L.; Serrano, M.A.C.; Wang, M.; Vachet, R.W.; Nugen, S.R. Phage-protease-peptide: A novel trifecta enabling multiplex detection of viable bacterial pathogens. App. Microbiol. Biotechnol. 2015, 99, 8177–8185. [Google Scholar] [CrossRef]
  17. Kretzer, J.W.; Schmelcher, M.; Loessner, M.J. Ultrasensitive and fast diagnostics of viable Listeria cells by CBD magnetic separation combined with A511::luxAB detection. Viruses 2018, 10, 626. [Google Scholar] [CrossRef]
  18. Kim, J.; Kim, M.; Kim, S.; Ryu, S. Sensitive detection of viable Escherichia coli O157:H7 from foods using a luciferase-reporter phage phiV10lux. Int. J. Food Microbiol. 2017, 254, 11–17. [Google Scholar] [CrossRef]
  19. Pulkkinen, E.M.; Hinkley, T.C.; Nugen, S.R. Utilizing in vitro DNA assembly to engineer a synthetic T7 Nanoluc reporter phage for Escherichia coli detection. Integr. Biol. 2019, 11, 63–68. [Google Scholar] [CrossRef]
  20. Whitehead, T.P.; Kricka, L.J.; Carter, T.J.N.; Thorpe, G.H.G. Analytical luminescence: Its potential in the clinical laboratory. Clin. Chem. 1979, 25, 1531–1546. [Google Scholar] [CrossRef]
  21. Coleman, J.E. Structure and mechanism of alkaline phosphatase. Annu. Rev. Biophy. Biomol. Struct. 1992, 21, 441–483. [Google Scholar] [CrossRef] [PubMed]
  22. Agrawal, D.K.; Wanner, B.L. A phoA structural gene mutation that conditionally affects formation of the enzyme bacterial alkaline phosphatase. J. Bacteriol. 1990, 172, 3180–3190. [Google Scholar] [CrossRef] [PubMed]
  23. Hoffman, C.S.; Wright, A. Fusions of secreted proteins to alkaline phosphatase: An approach for studying protein secretion. Proc. Natl. Acad. Sci. USA 1985, 82, 5107–5111. [Google Scholar] [CrossRef] [PubMed]
  24. Inouye, H.; Barnes, W.; Beckwith, J. Signal sequence of alkaline phosphatase of Escherichia coli. J. Bacteriol. 1982, 149, 434–439. [Google Scholar] [CrossRef]
  25. Chen, J.; Zhou, Y.; Wang, D.; He, F.; Rotello, V.M.; Carter, K.R.; Watkins, J.J.; Nugen, S.R. UV-nanoimprint lithography as a tool to develop flexible microfluidic devices for electrochemical detection. Lab Chip 2015, 15, 3086–3094. [Google Scholar] [CrossRef]
  26. Muller, B.H.; Lamoure, C.; Le Du, M.H.; Cattolico, L.; Lajeunesse, E.; Lemaître, F.; Pearson, A.; Ducancel, F.; Ménez, A.; Boulain, J.C. Improving Escherichia coli alkaline phosphatase efficacy by additional mutations inside and outside the catalytic pocket. ChemBioChem 2001, 2, 517–523. [Google Scholar] [CrossRef]
  27. Singh, S.; Hinkley, T.; Nugen, S.R.; Talbert, J.N. Fusion of carbohydrate binding module to mutant alkaline phosphatase for immobilization on cellulose. Biocatal. Agric. Biotechnol. 2018, 13, 265–271. [Google Scholar] [CrossRef]
  28. Hall, M.P.; Unch, J.; Binkowski, B.F.; Valley, M.P.; Butler, B.L.; Wood, M.G.; Otto, P.; Zimmerman, K.; Vidugiris, G.; MacHleidt, T.; et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 2012, 7, 1848–1857. [Google Scholar] [CrossRef]
  29. Oyama, H.; Kiguchi, Y.; Morita, I.; Miyashita, T.; Ichimura, A.; Miyaoka, H.; Izumi, A.; Terasawa, S.; Osumi, N.; Tanaka, H.; et al. NanoLuc luciferase as a suitable fusion partner of recombinant antibody fragments for developing sensitive luminescent immunoassays. Anal. Chim. Acta 2021, 1161, 238180. [Google Scholar] [CrossRef]
  30. Berlec, A.; Janež, N.; Sterniša, M.; Klančnik, A.; Sabotič, J. Expression of NanoLuc Luciferase in Listeria innocua for Development of Biofilm Assay. Front. Microbiol. 2021, 12, 636421. [Google Scholar] [CrossRef]
  31. Duong, M.M.; Carmody, C.M.; Nugen, S.R. Phage-based biosensors:: In vivo analysis of native T4 phage promoters to enhance reporter enzyme expression. Analyst 2020, 145, 6291–6297. [Google Scholar] [CrossRef] [PubMed]
  32. T7Select® 415-1 Cloning Kit|70015. Revised 2021. Available online: https://www.emdmillipore.com/US/en/product/T7Select-415-1-Cloning-Kit,EMD_BIO-70015#anchor_VMAP (accessed on 1 January 2022).
  33. He, J.; Sakaguchi, K.; Suzuki, T. Determination of the ribosome-binding sequence and spacer length between binding site and initiation codon for efficient protein expression in Bifidobacterium longum 105-A. J. Biosci. Bioeng. 2012, 113, 442–444. [Google Scholar] [CrossRef] [PubMed]
  34. Shine, J.; Dalgarno, L. Determinant of cistron specificity in bacterial ribosomes. Nature 1975, 254, 34–38. [Google Scholar] [CrossRef] [PubMed]
  35. Harron, D.W.G. The Textbook of Pharmaceutical Medicine, 7th ed.; BMJ Books: London, UK, 2013. [Google Scholar]
  36. Boulanger, R.; Kantrowitz, E. Characterization of a monomeric Escherichia coli alkaline phosphatase formed upon a single amino acid substitution. J. Biol. Chem. 2003, 278, 23497–23501. [Google Scholar] [CrossRef]
  37. Mie, M.; Niimi, T.; Mashimo, Y.; Kobatake, E. Construction of DNA-NanoLuc luciferase conjugates for DNA aptamer-based sandwich assay using Rep protein. Biotechnol. Lett. 2019, 41, 357–362. [Google Scholar] [CrossRef]
  38. Derman, A.I.; Beckwith, J. Escherichia coli alkaline phosphatase localized to the cytoplasm slowly acquires enzymatic activity in cells whose growth has been suspended: A caution for gene fusion studies. J. Bacteriol. 1995, 177, 3764. [Google Scholar] [CrossRef]
  39. Singh, P.; Sharma, L.; Kulothungan, S.R.; Adkar, B.V.; Prajapati, R.S.; Ali, P.S.S.; Krishnan, B.; Varadarajan, R. Effect of Signal Peptide on Stability and Folding of Escherichia coli Thioredoxin. PLoS ONE 2013, 8, 63442. [Google Scholar] [CrossRef]
  40. Mihali, A.; Rouh-Rong, J.; D’Eon, B.; Chiulli, A.; Agnew, B.; Gee, K.; Gee, M. Novel DynaLight™ Substrate with RapidGlow™ Enhancer: 1,2-Dioxetane Formulation for Application in Clinical Research Platforms; Public Communication; Life Technologies Corporation: Bedford, MA, USA, 2012. [Google Scholar]
  41. Calabretta, M.M.; Montali, L.; Lopreside, A.; Fragapane, F.; Iacoangeli, F.; Roda, A.; Bocci, V.; D’Elia, M.; Michelini, E. Ultrasensitive On-Field Luminescence Detection Using a Low-Cost Silicon Photomultiplier Device. Anal. Chem. 2021, 93, 7388–7393. [Google Scholar] [CrossRef]
  42. Warringer, J.; Blomberg, A. Evolutionary constraints on yeast protein size. BMC Evol. Biol. 2006, 6, 61. [Google Scholar]
  43. Hinkley, T.; Garing, S.; Singh, S.; Le Ny, A.; Nichols, K.; Peters, J.; Talbert, J.; Nugen, S. Reporter bacteriophage T7NLC utilizes a novel NanoLuc::CBM fusion for the ultrasensitive detection of Escherichia coli in water. Analyst 2018, 143, 4074. [Google Scholar] [CrossRef]
  44. Alonzo, F.; Hinkley, T.; Miller, A.; Calderon, R.; Garing, S.; Williford, J.; Clute-Reinig, N.; Spencer, E.; Friend, M.; Madan, D.; et al. A microfluidic device and instrument prototypes for the detection of Escherichia coli in water samples using a phage-based bioluminescence assay. Lab Chip 2022, 22, 2155. [Google Scholar] [CrossRef] [PubMed]
  45. Hinkley, T.; Garing, S.; Jain, P.; Williford, J.; Le Ny, A.-L.; Nichols, K.; Peters, J.; Talbert, J.; Nugen, S. A Syringe-Based Biosensor to Rapidly Detect Low Levels of Escherichia Coli (ECOR13) in Drinking Water Using Engineered Bacteriophages. Sensors 2020, 20, 1953. [Google Scholar] [CrossRef] [Green Version]
  46. Zurier, H.; Duong, M.; Goddard, J.; Nugen, S. Engineering Biorthogonal Phage-Based Nanobots for Ultrasensitive, in Situ Bacteria Detection. ACS Appl. Bio. Mater. 2020, 3, 5824. [Google Scholar] [CrossRef] [PubMed]
  47. Dow, P.; Kotz, K.; Gruszka, S.; Holder, J.; Fiering, J. Acousitic Seperation in Plastic Microfluidics for Rapid Detection of Bacteria in Blood Using Engineered Bacteriophage. Lab Chip 2018, 18, 923. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. (a) Details of the reporter genes ALP* and NLuc constructs in the pET20b+ vector. The N-terminal pelB secretion signal was removed from the vector during plasmid synthesis. (b) Details of the reporter genes ALP* and NLuc constructs in the T7 phage genome.
Scheme 1. (a) Details of the reporter genes ALP* and NLuc constructs in the pET20b+ vector. The N-terminal pelB secretion signal was removed from the vector during plasmid synthesis. (b) Details of the reporter genes ALP* and NLuc constructs in the T7 phage genome.
Bioengineering 09 00479 sch001
Figure 1. Detection of NLuc and ALP* in the soluble fraction of E. coli Bl21.
Figure 1. Detection of NLuc and ALP* in the soluble fraction of E. coli Bl21.
Bioengineering 09 00479 g001
Figure 2. Signal-to-noise ratio (S/N) versus the amount of enzyme. (a) ALP*/DynaLight and (b) NLuc/Nano-Glo. S/N of 3:1 is indicated by a dashed line (n = 3).
Figure 2. Signal-to-noise ratio (S/N) versus the amount of enzyme. (a) ALP*/DynaLight and (b) NLuc/Nano-Glo. S/N of 3:1 is indicated by a dashed line (n = 3).
Bioengineering 09 00479 g002
Figure 3. Reporter protein expressed following phage infection of E. coli BL21 cells. Different letters indicate statistically significant differences (p < 0.05) in protein expression (n = 3).
Figure 3. Reporter protein expressed following phage infection of E. coli BL21 cells. Different letters indicate statistically significant differences (p < 0.05) in protein expression (n = 3).
Bioengineering 09 00479 g003
Figure 4. Signal to noise ratio versus colony forming units (CFU) available for infection in 880 mL. (a) T7ALP*/DynaLight and (b) T7NLuc/Nano-Glo. S/N of 3:1 is indicated by a dashed line. (n = 3).
Figure 4. Signal to noise ratio versus colony forming units (CFU) available for infection in 880 mL. (a) T7ALP*/DynaLight and (b) T7NLuc/Nano-Glo. S/N of 3:1 is indicated by a dashed line. (n = 3).
Bioengineering 09 00479 g004
Table 1. Primer sets used to generate and NLuc and ALP* gene inserts for the ligation with the T7Select® phage vector arms.
Table 1. Primer sets used to generate and NLuc and ALP* gene inserts for the ligation with the T7Select® phage vector arms.
NLucRestriction SiteRBSSTOPSTARTPrimer
Forward PrimerEcoRI
GAATTC
AGGAGGTGATGAATG5′CGGGAATTCATGATGAGCGAGGAGGGCGATGATGGTCTTCACACTC 3′
Reverse PrimerHindIII
AAGCTT
TGA 5′CGGAAGCTTCTAGTGGTGGTGGTGGTGGTGCGCCAG 3′
ALP*Restriction SiteRBSSTOPSTARTPrimer
Forward PrimerEcoRI
GAATTC
AGGAGGTGATGAATG5′CGGCGGAATTCATGATGAGCGAGGAGGCGCATGCGTACACCGGAAATGCCG 3′
Reverse PrimerHindIII
AAGCTT
TGA 5′CGGAAGCTTTCAGTGGTGGTGGTGGTGGTGCTCGAGTTTCAG 3′
Table 2. Summary of Selected NLuc and ALP* Reporter phage-based detection assays.
Table 2. Summary of Selected NLuc and ALP* Reporter phage-based detection assays.
Ref.Type of PhageE. coli StrainReporter ModificationPhage Available for InfectionPre/Enrich-ment of
E. coli
Incubation Time-VolumeReporter Concentration Reaction
Volume
Detection MatrixDetection MethodDefinition of the Detection Limit-
Total Assay Time
[4]T7_ALP*BL21 derivativeCBM(Cex)1:10
CFU:PFU
4 h2 h-
100 mL
Magnetic cellulose particles60 µLLBAbs3LOQ: <10 CFU/100 mL-8 h
[7]T7_ALP*BL21His-tag107 PFU/mL-16 h--50 µLLBAbs7LOD: ∼1 × 105 CFU/mL
[10]T7_NLucBL21CBM2a/pelB2 × 109 PFU8–12 h1.5 h-
2 mL
Cellulose filter~300 µLDrinking waterAbs/LUMatched EPA results
[19]T7_NLucBL21CBM/pelB106 PFU1 h2 h-
1 mL
-200 µLLBLU6Detectable signal: 5 × 102 CFU/mL-2 h
[43]T7_NLucBL21CBM/pelB109 PFU1 h (pre-)1.5 h-126 mLMicro-crystalline cellulose100 µLDrinking waterLU4LOD: <10 CFU/mL-3 h
[44]T7_NLucBL21CBM1.25 × 108 PFU-3 h-
0.25 mL
Nitro-cellulose membrane75 µLDrinking waterLU1LOD: 4.1 CFU-5.5 h
[45]T7_NLucECOR13CBM107 PFU/mL3 h (pre-)1.5 h-Cellulose filter-Drinking waterLU2LOD: <20 CFU-5 h
[46]T4_NLucECOR13CBM107-6 PFU3 h (pre-)3 h-
0.5 mL
Cellulose filter50 µLDrinking waterLU5LOD: <10 CFU/100 mL-7 h
[47]K1E_NLucK1 - 106 PFU - 1 h-
0.1 mL
--LBLU8LLOD: 8 CFU/well-1 h
Definition of Limit of Detection used by each assay. 1LOD—Negative control (phage only) plus three standard deviations. 2LOD—Mean blank plus three times the standard deviation of the blank. 3LOQ: Limit of Quantitation. Ten times the standard deviation of the mean blank divided by the regression slope. 4LOD—Sum of the negative control and three standard deviations. 5LOD—Three standard deviations above mean baseline luminescence. 6Detectable Signal—Negative control (phage only) and its standard deviation was considered. 7LOD— Positive signals above background. 8LLOD: Lower Limit of Detection. Addition of three times the standard deviation of the average measurement of the negative control to the average negative control value.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wijeratne, S.; Bakshi, A.; Talbert, J. Comparative Analysis of NanoLuc Luciferase and Alkaline Phosphatase Luminescence Reporter Systems for Phage-Based Detection of Bacteria. Bioengineering 2022, 9, 479. https://doi.org/10.3390/bioengineering9090479

AMA Style

Wijeratne S, Bakshi A, Talbert J. Comparative Analysis of NanoLuc Luciferase and Alkaline Phosphatase Luminescence Reporter Systems for Phage-Based Detection of Bacteria. Bioengineering. 2022; 9(9):479. https://doi.org/10.3390/bioengineering9090479

Chicago/Turabian Style

Wijeratne, Shalini, Arindam Bakshi, and Joey Talbert. 2022. "Comparative Analysis of NanoLuc Luciferase and Alkaline Phosphatase Luminescence Reporter Systems for Phage-Based Detection of Bacteria" Bioengineering 9, no. 9: 479. https://doi.org/10.3390/bioengineering9090479

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop